Soiken Holdings Inc.

Soiken Holdings Inc. develops biomarkers in Japan. It also develops and sells cosmetics and dietary supplements containing imidapeptides, licenses and develops biomarker technology, and provides marketing research and post-marketing surveys for dietary supplements. The company researches, develops, and sells functional materials such as lactoferrin, as well as pharmaceutical products derived from ascochlorin. It offers clinical evaluation tests for foodstuffs using biomarker technology, supports pharmaceutical clinical research and epidemiology studies, and provides services to health insurance societies, including contracted health guidance, specific health checkup promotion for dependents of insured, and diabetes prevention services. Incorporated in 1994, it is headquartered in Toyonaka, Japan.